GlassScriptPhysician profile
Purvi Patel
NPI 1386993202
$10,076.20
in general payments reported to CMS, 2019-2025
45 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,151 · 2020: $932 · 2021: $1,364 · 2022: $2,115 · 2023: $1,747 · 2024: $1,686 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,206 · Travel and Lodging: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,206.32 |
| Travel and Lodging | $307.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,879.13 | 2019-2025 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $1,025.27 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $732.21 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $655.41 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Accolade Sr |
| Painteq LLC | $532.70 | 2022-2024 | Painteq |
| Curonix LLC | $357.39 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $346.68 | 2021-2024 | Intellis Adaptivestim |
| Nalu Medical, INC. | $333.78 | 2023-2025 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $298.96 | 2022 | |
| Nevro Corp. | $288.15 | 2022-2024 | Senza |
| Si-Bone, INC. | $210.47 | 2019-2024 | |
| Spinal Simplicity, LLC | $204.17 | 2023 | Ha Minuteman G3-R |
| Scilex Pharmaceuticals INC. | $183.33 | 2019-2023 | Ztlido |
| Grt US Holding, INC. | $159.87 | 2020-2021 | |
| Mml US, INC. | $154.96 | 2024 | Reactiv8 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Purvi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.